Meeting NewsVideoFrom OSN Europe

VIDEO: Topical treatment of AMD shows promise in early stages of clinical trial

VIENNA — At the Euretina meeting, Hemal Mehta, MD, speaks about the early results of the PanOptica clinical trial on a new molecule for the topical treatment of age-related macular degeneration, which could revolutionize the way the disease is treated.

VIENNA — At the Euretina meeting, Hemal Mehta, MD, speaks about the early results of the PanOptica clinical trial on a new molecule for the topical treatment of age-related macular degeneration, which could revolutionize the way the disease is treated.

    See more from Euretina Congress